Works by Jacobs, Tom


Results: 98
    1
    2

    Neural network algorithm for detection of erosions and ankylosis on CT of the sacroiliac joints: multicentre development and validation of diagnostic accuracy.

    Published in:
    European Radiology, 2023, v. 33, n. 11, p. 8310, doi. 10.1007/s00330-023-09704-y
    By:
    • Van Den Berghe, Thomas;
    • Babin, Danilo;
    • Chen, Min;
    • Callens, Martijn;
    • Brack, Denim;
    • Maes, Helena;
    • Lievens, Jan;
    • Lammens, Marie;
    • Van Sumere, Maxime;
    • Morbée, Lieve;
    • Hautekeete, Simon;
    • Schatteman, Stijn;
    • Jacobs, Tom;
    • Thooft, Willem-Jan;
    • Herregods, Nele;
    • Huysse, Wouter;
    • Jaremko, Jacob L.;
    • Lambert, Robert;
    • Maksymowych, Walter;
    • Laloo, Frederiek
    Publication type:
    Article
    3
    4
    5
    6

    Robbing Peter to pay Paul.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 11, p. 1341, doi. 10.1038/nbt1106-1341
    By:
    • Jacobs, Tom
    Publication type:
    Article
    7

    Biotech buybacks—good or bad?

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 10, p. 1207, doi. 10.1038/nbt1006-1207
    By:
    • Jacobs, Tom
    Publication type:
    Article
    8

    The protection racket.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 9, p. 1081, doi. 10.1038/nbt0906-1081
    By:
    • Jacobs, Tom
    Publication type:
    Article
    9
    10
    11

    A special biotech speculation.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 6, p. 622, doi. 10.1038/nbt0606-622
    By:
    • Jacobs, Tom
    Publication type:
    Article
    12

    PEGging biotech growth.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 5, p. 506, doi. 10.1038/nbt0506-506
    By:
    • Jacobs, Tom
    Publication type:
    Article
    13

    My worst biotech investment.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 4, p. 401, doi. 10.1038/nbt0406-401
    By:
    • Jacobs, Tom
    Publication type:
    Article
    14

    A rollercoaster ride.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 3, p. 284, doi. 10.1038/nbt0306-284
    By:
    • Jacobs, Tom
    Publication type:
    Article
    15
    16
    17

    Trials and error.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 12, p. 1481, doi. 10.1038/nbt1205-1481
    By:
    • Jacobs, Tom
    Publication type:
    Article
    18

    The number on biotech indexes.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 11, p. 1356, doi. 10.1038/nbt1105-1356
    By:
    • Jacobs, Tom
    Publication type:
    Article
    19

    A taxing dilemma.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 10, p. 1219, doi. 10.1038/nbt1005-1219
    By:
    • Jacobs, Tom
    Publication type:
    Article
    20
    21

    No pain, no gain?

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 8, p. 934, doi. 10.1038/nbt0805-934
    By:
    • Jacobs, Tom
    Publication type:
    Article
    22

    When a long shot is worth a shot.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 7, p. 805, doi. 10.1038/nbt0705-805
    By:
    • Jacobs, Tom;
    • Fischer, Jeff
    Publication type:
    Article
    23
    24

    Beware the biotech barker.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 5, p. 538, doi. 10.1038/nbt0505-538
    By:
    • Jacobs, Tom
    Publication type:
    Article
    25

    Diversify to multiply.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 4, p. 419, doi. 10.1038/nbt0405-419
    By:
    • Jacobs, Tom
    Publication type:
    Article
    26
    27

    Great company, bad stock.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 2, p. 173, doi. 10.1038/nbt0205-173
    By:
    • Jacobs, Tom
    Publication type:
    Article
    28

    Time to kick that drug habit.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 1, p. 23, doi. 10.1038/nbt0105-23
    By:
    • Jacobs, Tom
    Publication type:
    Article
    29

    Biotechs for pennies?

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 12, p. 1509, doi. 10.1038/nbt1204-1509
    By:
    • Jacobs, Tom
    Publication type:
    Article
    30

    The best companies bare all.

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 11, p. 1363, doi. 10.1038/nbt1104-1363
    By:
    • Jacobs, Tom
    Publication type:
    Article
    31

    More than meets the eyes?

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 10, p. 1221, doi. 10.1038/nbt1004-1221
    By:
    • Jacobs, Tom
    Publication type:
    Article
    32
    33

    Biotech IPOs--flop or pop?

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 8, p. 949, doi. 10.1038/nbt0804-949
    By:
    • Jacobs, Tom
    Publication type:
    Article
    34

    Bargains in the basement.

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 7, p. 813, doi. 10.1038/nbt0704-813
    By:
    • Jacobs, Tom
    Publication type:
    Article
    35

    Diversifying in biotech.

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 6, p. 661, doi. 10.1038/nbt0604-661
    By:
    • Jacobs, Tom
    Publication type:
    Article
    36
    37
    38

    Biotech IPOs: handle with care.

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 12, p. 1437, doi. 10.1038/nbt1203-1437
    By:
    • Jacobs, Tom
    Publication type:
    Article
    39
    40
    41

    Going short on biotech.

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 10, p. 1133, doi. 10.1038/nbt1003-1133
    By:
    • Jacobs, Tom
    Publication type:
    Article
    42

    Is Elan a turnaround?

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 9, p. 985, doi. 10.1038/nbt0903-985
    By:
    • Jacobs, Tom
    Publication type:
    Article
    43

    The stampede to convertibles.

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 8, p. 855, doi. 10.1038/nbt0803-855
    By:
    • Jacobs, Tom
    Publication type:
    Article
    44

    Another clue to biotech value.

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 7, p. 746, doi. 10.1038/nbt0703-746
    By:
    • Jacobs, Tom
    Publication type:
    Article
    45

    Hidden in plain view.

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 6, p. 603, doi. 10.1038/nbt0603-603
    By:
    • Jacobs, Tom
    Publication type:
    Article
    46

    Splurge or merge?

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 5, p. 485, doi. 10.1038/nbt0503-485
    By:
    • Jacobs, Tom
    Publication type:
    Article
    47

    Fighting company spin.

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 4, p. 357, doi. 10.1038/nbt0403-357
    By:
    • Jacobs, Tom
    Publication type:
    Article
    48
    49

    Who's minding the store?

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 1, p. 17, doi. 10.1038/nbt0103-17
    By:
    • Jacobs, Tom
    Publication type:
    Article
    50

    The margin of safety.

    Published in:
    Nature Biotechnology, 2002, v. 20, n. 12, p. 1191, doi. 10.1038/nbt1202-1191
    By:
    • Jacobs, Tom
    Publication type:
    Article